NMPA Approval

Amlodipine Besilate and Benazepril Hydrochloride Capsules

Approval Number

国药准字H20253881

Company地奥集团成都药业股份有限公司

Registration Date

April 15, 2025

Drug Information

Generic Name

氨氯地平贝那普利胶囊

Dosage Form

胶囊剂

Strength

每粒含苯磺酸氨氯地平5mg（按 C₂₀H₂₅ClN₂O₅计）与盐酸贝那普利10mg

Drug Type

化学药品

Registration Date

April 15, 2025

Company Information

Applicant Company

Company Name地奥集团成都药业股份有限公司

Company Address

成都高新区合瑞路518号

Manufacturing Company

Company Name地奥集团成都药业股份有限公司

Company Address

成都市高新区合瑞路518号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

氨氯地平贝那普利胶囊 - NMPA 批准文号 | MedPath